{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1164.26","meta":{"versionId":"9","lastUpdated":"2021-04-29T01:00:16.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"LUGPA Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2021-04-29"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.26","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1164.26"}],"version":"20210429","name":"DentalIndicationsSurroundingAdministrationOfMedicationsToTreatOsteoporosisInMen","title":"Dental indications surrounding administration of medications to treat osteoporosis in men","status":"active","experimental":false,"date":"2021-04-29T01:00:16-04:00","publisher":"LUGPA Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: This set of values focuses on dental indications prior to or when administering medications for osteoporosis to men during urology care.),(Data Element Scope: The intent of this data element is to identify dental indications when medications for osteoporosis are being considered or during their administration.),(Inclusion Criteria: osteonecrosis of the jaw),(Exclusion Criteria: none)","compose":{"include":[{"system":"http://hl7.org/fhir/sid/icd-10-cm","concept":[{"code":"M87.180","display":"Osteonecrosis due to drugs, jaw"}]}]},"expansion":{"identifier":"urn:uuid:3efe31a3-ea09-4229-9cfc-be78e00d7e62","timestamp":"2023-12-10T22:31:05-05:00","total":1,"contains":[{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"M87.180","display":"Osteonecrosis due to drugs, jaw"}]}}